Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration-Reference-Cited by-同舟云学术

Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration

Published:2024-08-16 Issue: Volume: Page:
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Frontzek Fabian^ORCID,Renaud Loïc^ORCID,Dührsen Ulrich,Poeschel Viola,Bernard Sophie,Chartier Loïc,Ketterer Nicolas,Récher Christian,Fitoussi Olivier,Held Gerhard,Casasnovas Olivier^ORCID,Haioun Corinne,Mounier Nicolas,Tilly Hervé,Morschhauser Franck^ORCID,Le Gouill Steven,Karsten Imke E.,Duns Gerben,Steidl Christian^ORCID,Scott David W.,Klapper Wolfram^ORCID,Rosenwald Andreas,Ott German,Molina Thierry^ORCID,Lenz Georg,Ziepert Marita,Altmann Bettina,Thieblemont Catherine,Schmitz Norbert^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41375-024-02371-y.pdf

Reference70 articles.

1. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36:1720–48.

2. Crump M, Neelapu SS, Farooq U, Van Den Neste E, Kuruvilla J, Westin J, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130:1800–8.

3. Thieblemont C, Altmann B, Frontzek F, Renaud L, Chartier L, Ketterer N, et al. Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis. Blood Adv. 2023;7:3968–77.

4. Schmitz N, Zeynalova S, Nickelsen M, Kansara R, Villa D, Sehn LH, et al. CNS International Prognostic Index: A risk model for CNS relapse in patients with diffuse large B-Cell lymphoma treated with R-CHOP. J Clin Oncol. 2016;34:3150–6.

5. Schmitz N, Zeynalova S, Glass B, Kaiser U, Cavallin-Stahl E, Wolf M, et al. CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group. Ann Oncol. 2012;23:1267–73.